ORLANDO, Fla., Feb. 26, 2018 /PRNewswire/ — At Pittcon 2018, Bruker (NASDAQ: BRKR) this week will highlight various innovative analytical systems and new high-value solutions for food analysis, pharmaceutical, clinical research, and materials science applications. At Bruker’s Pittcon press conference, Professor Jeremy Nicholson from Imperial College London, UK will discuss ‘The Future of Molecular Phenomics in... Read more
2018-02-25 | Corporate Three new subsidiaries of Anton Paar have recently officially started operations. Anton Paar New Zealand celebrated the opening with CEO Friedrich Santner. He explained the history of Anton Paar in New Zealand and talked about the manifold applications of our instruments. The opening ceremony was attended by the team that helped set up... Read more
BERWYN, Pa., Feb. 20, 2018 /PRNewswire/ — AMETEK, Inc. (NYSE: AME) today announced that its Board of Directors has elected Mark Scheuer as Vice President, Environmental, Health & Safety (EH&S). Mr. Scheuer currently serves as Director, Corporate Compliance. “I am pleased to announce Mark’s promotion to Vice President. He has done an outstanding job supporting our... Read more
BILLERICA, Mass., Feb. 14, 2018 /PRNewswire/ — Bruker is pleased to announce that AOAC International has approved the MALDI Biotyper solution for two new Official Methods of Analysis (OMA) for the confirmation and identification of pathogenic and non-pathogenic bacteria. The two methods include some of the most common food pathogens, including Salmonella spp (spp means all... Read more
CONTACT: Nate Banner, Neogen Corporation, 517/372-9200 LANSING, Mich., Feb. 1, 2018 — Neogen Corporation (NASDAQ: NEOG) today announced that it has released BetaStar® Advanced — the easiest method to test for antibiotics in milk. BetaStar Advanced has been reviewed by the FDA, approved for use by the National Conference on Interstate Milk Shipments (NCIMS), and validated by the AOAC... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that a federal jury in San Francisco has ruled in its favor in a patent infringement suit filed against Ariosa Diagnostics, Inc., now owned by Roche. The jury found that both Ariosa’s previous and current version of the Harmony non-invasive prenatal test (NIPT) infringe US Patent 8,318,430... Read more
MENLO PARK, California and SHENZHEN, China, Jan. 25, 2018 (GLOBE NEWSWIRE) — BGI, one of the world’s largest genomics organizations, and Pacific Biosciences of California, Inc. (Nasdaq: PACB), the leader in long-read sequencing, today announced an agreement by BGI Genomics to purchase an additional 10 Sequel® Systems. This will significantly expand the capacity for Single Molecule, Real-Time... Read more
January 19, 2018 For LabSolutions LCMS Mycotoxins are highly toxic chemical byproducts from fungi commonly found in crops, and residual content in foods are regulated the world over. This method package provides simultaneous multi-component analysis conditions for mycotoxins subject to the regulations in Japan, the USA, the EU, and China. Analytical Methods for 27 Mycotoxins... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today the launch of the iSeq™ 100 Sequencing System. The new, next-generation sequencing (NGS) system delivers exceptional data accuracy, at a low capital cost, making Illumina technology available to virtually any lab. The combination of the company’s proven sequencing by synthesis (SBS) chemistry, along with the complementary metal-oxide-semiconductor... Read more
Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology Industry-leading amplicon solution facilitates targeted next-generation sequencing in multiple application areas Thermo Fisher Scientific and Illumina, Inc.(NASDAQ: ILMN) today announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who conduct... Read more